Acadia Pharmaceuticals Stock Sinks After Schizophrenia Drug Study Falls Short
Key Takeaways Acadia Pharmaceuticals’ drug missed endpoints for treating schizophrenia patients, news that sent Acadia …
Key Takeaways Acadia Pharmaceuticals’ drug missed endpoints for treating schizophrenia patients, news that sent Acadia …
Key Takeaways Alcoa has finalized a deal to buy Alumina Limited for about $2.2 billion. …
Key Takeaways U.S. equities advanced at midday Tuesday, March 12, 2024 as tech stocks surged …
Key Takeaways Vail Resorts reported fiscal 2024 second-quarter earnings and revenue that missed estimates as …
Key Takeaways Activist investor Dan Loeb’s hedge fund Third Point LLC and Saddle Point Management …
Key Takeaways The S&P 500 slipped 0.1% on Monday, March 11, 2024, ahead of inflation …
Key Takeaways Elon Musk said that xAI, his artificial intelligence startup, will open-source its chatbot …
Key Takeaways U.S. equities were mixed at midday Monday, March 11, 2024 as a survey …
Episode 178 of the Investopedia Express with Caleb Silver (March 11, 2024) <img src='https://www.investopedia.com/thmb/xXHvuwUSlvoo1wqmeipx19q7n0I=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/DiggingforAnswersonWhyGoldisataRecordHigh-fb98c29f5618462ab20fa77f3efe5efd.jpg' alt=' …
Key Takeaways Applied Materials Inc. announced Monday it was raising its quarterly dividend 25%, to …